Workflow
Cost Escalation
icon
Search documents
MP Continues to Report Operating Losses: Can It Bounce Back?
ZACKSยท 2025-09-19 12:46
Core Insights - MP Materials Corp. has faced operating losses and negative operating margins for eight consecutive quarters due to rising costs [1][11] - The company's cost of sales nearly doubled in 2024, reaching $192.6 million from $92.7 million in 2023, with costs rising to approximately 94% of revenues from 37% a year earlier [1][4] - In the first half of 2025, the cost of sales increased by 29% compared to the same period last year, driven by the higher costs associated with producing separated rare earth products [2][4] Cost Structure - The increase in costs is attributed to the production of separated products, which is more expensive than producing rare earth concentrates due to additional processing requirements, including chemical reagents, labor, maintenance, and consumables [2][4] - Selling, general and administrative (SG&A) expenses rose by 5% in 2024 and by 21% in the first half of 2025 as the company expanded its workforce to support downstream operations [3][4] Operating Performance - The sharp rise in both cost of sales and SG&A expenses has led to higher total operating expenses, resulting in continued operating losses for MP Materials [4][11] - The company is expected to maintain elevated costs through 2025 as it expands production of separated rare earth products and magnetic precursor products [4] Production and Revenue Outlook - NdPr production volumes are increasing due to process optimization, and higher production and sales volumes, along with improved pricing, are anticipated to boost NdPr revenues in upcoming quarters [5] - The Zacks Consensus Estimate for MP Materials' 2025 earnings is projected at a loss of $0.34 per share, but a significant improvement is expected in 2026 with earnings estimated at $0.91 per share [13] Market Performance - MP Materials' shares have surged by 362.4% this year, significantly outperforming the industry's growth of 21.3% [12] - The company is currently trading at a forward 12-month price/sales multiple of 25.39X, which is a substantial premium compared to the industry's 1.18X [14]